FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, concerns a pharmaceutical composition for treating sexual and premenstrual disorders containing flibanserin 1, as one active substance in a combination with at least another one active substance 2 specified in a group consisting of melanokortin agonists, prostaglandin E1 agonists increasing the level of cyclic guanosine-3',5'-monophosphate (cGMP) agent (preferentially PDE V inhibitors), 5-HT1A agonists, dopamine agonists, 5-HT2A/C antagonists, selective androgen receptor modulators (SARM), selective oestrogen receptor modulators (SORM), oestrogens, androgens and α-adrenoreceptor antagonists. Also, the invention concerns a method of treating sexual and premenstrual disorders.
EFFECT: composition shows high efficacy.
27 cl, 10 ex
